Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $6,886 - $7,908
-266 Reduced 2.51%
10,350 $287,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $1,332 - $1,730
51 Added 0.48%
10,616 $305,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $6,289 - $7,351
-196 Reduced 1.82%
10,565 $350,000
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $14,592 - $16,883
-404 Reduced 3.62%
10,761 $394,000
Q1 2023

May 08, 2023

BUY
$39.39 - $51.28 $1,142 - $1,487
29 Added 0.26%
11,165 $455,000
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $15,155 - $19,783
363 Added 3.37%
11,136 $571,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $86,163 - $105,183
1,969 Added 22.36%
10,773 $471,000
Q2 2022

Aug 02, 2022

SELL
$46.53 - $55.17 $21,543 - $25,543
-463 Reduced 5.0%
8,804 $462,000
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $16,744 - $20,748
366 Added 4.11%
9,267 $480,000
Q1 2021

Apr 20, 2021

BUY
$33.49 - $37.77 $20,261 - $22,850
605 Added 7.29%
8,901 $322,000
Q4 2020

Jan 28, 2021

BUY
$33.47 - $42.56 $20,082 - $25,536
600 Added 7.8%
8,296 $305,000
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $6,584 - $7,472
200 Added 2.67%
7,696 $302,000
Q3 2019

Nov 05, 2019

SELL
$32.49 - $42.13 $27,096 - $35,136
-834 Reduced 10.01%
7,496 $269,000
Q2 2019

Jul 24, 2019

BUY
$36.98 - $41.52 $6,804 - $7,639
184 Added 2.26%
8,330 $361,000
Q1 2019

May 03, 2019

SELL
$37.5 - $41.2 $277,125 - $304,468
-7,390 Reduced 47.57%
8,146 $346,000
Q4 2018

Feb 06, 2019

BUY
$38.47 - $43.86 $597,669 - $681,408
15,536 New
15,536 $678,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Business Financial Services, Inc. Portfolio

Follow First Business Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Business Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Business Financial Services, Inc. with notifications on news.